Royal DSM has kicked the integration of its new €800m wholly-owned subsidiary, Martek Biosciences Corporation, into life by establishing a special integration unit to manage the US-Dutch-Swiss deal.
Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...
The European Food Safety Authority (EFSA) has rejected a Martek Biosciences Corporation health claim submission relating infant brain and eye development with DHA (omega-3) and ARA (omega-6) consumption.
Martek Biosciences Corporation, the US group which produces DHA and
EPA omega-3 ingredients, is to consolidate all its sales activities
related to products for the food and beverage industry in a bid to
streamline operations.
Martek Biosciences Corporation is to buy docosahexaenoic acid (DHA)
producer OmegaTech, giving it a further foothold in the growing
market for fortified foods. Martek said it would become the world
leader in fermentation-derived DHA...
US company Martek Biosciences Corporation that develops,
manufactures and sells products from microalgae for nutritional
foods, announced recently that it has sold the assets of its stable
isotope business unit to Spectra Gases, Inc.,...